Are "high-risk" patients with differentiated thyroid cancer "healthy patients"?

NuklearMedizin

Volumn 47, Issue 5, 2008, Pages 179-180

  Riemann, B ^a,b   Schober, O ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

CANCER INFILTRATION; CANCER STAGING; CANCER SURVIVAL; DIFFERENTIATED THYROID CANCER; DRUG MEGADOSE; EDITORIAL; HIGH RISK PATIENT; HUMAN; OVERALL SURVIVAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL TIME; THYROID CANCER; MORTALITY; NOTE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; THYROID TUMOR;

HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; THYROID NEOPLASMS;

EID: 58149335379     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Biermann M, Pixberg KM, Dörr U et al. Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice. Nuklearmedizin 2005; 44: 229-234, 236-237.
2. Dietlein M, Dressler J, Eschner W et al. Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3). Nuklearmedizin 2007; 46: 206-212.
3. Dietlein M, Dressler J, Eschner W et al. Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3). Nuklearmedizin 2007; 46: 213-219.
4. Eichhorn W, Tabler H, Lippold R et al. Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 2003; 13: 949-958.
5. Eustatia-Rutten CFA, Corssmit EPM, Biermasz NR et al. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006; 91 : 313-319.
6. 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer. Nuklearmedizin 2007; 46:224-231.
7. Peppercorn JM, Weeks JC, Cook EF et al. Comparison of outcomes in cancer patients treated within and outside clincal trials: conceptual framework and structured review. Lancet 2004; 363: 263-270.
8. Rahbar K, Hutzenlaub V, Fischer RJ et al. Risk-profile and outcome of small papillary and follicular thyroid carcinomas. Nuklearmedizin 2008; 47: 188-193.
9. Welsch M, Abeln M, Zaplatnikov K et al. Multiparameter scoring system for the prognosis of differentiated thyroid cancer. Nuklearmedizin 2007; 46: 3-8.